Compare BioNano Genomics Inc (BNGO) vs McDonald's Corp (MCD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs McDonald's Corp — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.31M), while McDonald's Corp trades at $273.79 (market cap $193.70B). The key difference: McDonald's Corp is far larger — about 14553× BioNano Genomics Inc's market cap, and McDonald's Corp pays a 2.72% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | MCD | |
|---|---|---|
Market Cap | $13.31M | $193.70B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.92 | $341.06 |
52-Week Low | $1.06 | $262.80 |
Enterprise Value | $15.92M | $247.47B |
Volume | — | 2,230,036 |
Dividend Yield | — | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
McDonald's (MCD) trades at $274.15, down slightly by 0.12% on the day, with technical indicators showing a neutral overall signal. The company demonstrates strong fundamentals with consistent revenue growth, reaching $26.89 billion in 2025, and robust profitability with a 31.72% net income margin. Recent earnings have consistently beaten expectations, and the company has announced a new global growth strategy focused on automation and menu innovation to drive future performance.
The outlook for MCD is positive, supported by strong analyst consensus with a $322.45 price target implying significant upside. Key opportunities include the successful execution of its new growth plan and its defensive qualities in a challenging economy. Primary risks involve inflationary pressures on franchisee margins and intense competition in the quick-service restaurant sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About McDonald's Corp
McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.
Read more on MCD →
